Back to Search
MICHAEL BORRELLO, MD
MD
Interventional Pain Medicine Physician
NPI: 1265476857IndividualAccepts Medicare
Specialties, Licenses & Credentials
Pain Medicine — Interventional Pain Medicine
Code: 208VP0014X
C163019(CA)
Education
UNIVERSITY OF TEXAS MEDICAL SCHOOL AT HOUSTON
Class of 1990
Research & Publications (20)
RET/PTC1-driven neoplastic transformation and proinvasive phenotype of human thyrocytes involve Met induction and beta-catenin nuclear translocation.
PMID 19107227·Neoplasia·2009
7-preclinical
A randomized, double-blind, crossover study of once-daily dexmethylphenidate in children with attention-deficit hyperactivity disorder: rapid onset of effect.
PMID 18601306·CNS Drugs·2008
2-rct
SH2B1beta adaptor is a key enhancer of RET tyrosine kinase signaling.
PMID 17471236·Oncogene·2007
7-preclinical
The dependence receptor Ret induces apoptosis in somatotrophs through a Pit-1/p53 pathway, preventing tumor growth.
PMID 17380130·EMBO J·2007
4-observational
C35 (C17orf37) is a novel tumor biomarker abundantly expressed in breast cancer.
PMID 17121940·Mol Cancer Ther·2006
4-observational
Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene.
PMID 16203990·Proc Natl Acad Sci U S A·2005
4-observational
Biological effects of the dual phenotypic Janus mutation of ret cosegregating with both multiple endocrine neoplasia type 2 and Hirschsprung's disease.
PMID 14715928·Mol Endocrinol·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 356 MOUNTAIN VIEW DR, SUITE 200
COLCHESTER, VT 05446 - Phone
- (802) 655-9798
Quick Facts
- NPI
- 1265476857
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 36
- Publications
- 20
Are you this provider?
Claim Your Profile